- Conditions
- Parkinson Disease
- Interventions
- Biological/Vaccine: Allogeneic HB-adMSCs, Placebo
- Biological · Other
- Lead sponsor
- Hope Biosciences Research Foundation
- Industry
- Eligibility
- 45 Years to 80 Years
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2025
- U.S. locations
- 1
- States / cities
- Sugar Land, Texas
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–24
of 47
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Parkinson Disease
- Interventions
- NLY01, Vehicle
- Drug
- Lead sponsor
- Neuraly, Inc.
- Industry
- Eligibility
- 30 Years to 80 Years
- Enrollment
- 255 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2023
- U.S. locations
- 60
- States / cities
- Birmingham, Alabama • Phoenix, Arizona • Scottsdale, Arizona + 49 more
- Conditions
- Parkinson Disease
- Interventions
- Vibrotactile coordinated reset
- Device
- Lead sponsor
- Stanford University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 1
- States / cities
- Stanford, California
- Conditions
- Parkinsons Disease
- Interventions
- Prasinezumab, Placebo
- Drug
- Lead sponsor
- Hoffmann-La Roche
- Industry
- Eligibility
- 50 Years to 85 Years
- Enrollment
- 586 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2031
- U.S. locations
- 31
- States / cities
- Birmingham, Alabama • Phoenix, Arizona • Fullerton, California + 27 more
- Conditions
- Parkinson's Disease, Healthy
- Interventions
- BIIB054, Placebo
- Drug
- Lead sponsor
- Biogen
- Industry
- Eligibility
- 40 Years to 80 Years
- Enrollment
- 66 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2015 – 2017
- U.S. locations
- 9
- States / cities
- Washington D.C., District of Columbia • Hallandale, Florida • Oviedo, Florida + 6 more
- Conditions
- Early Parkinson Disease
- Interventions
- K0706, placebo
- Drug · Other
- Lead sponsor
- Sun Pharma Advanced Research Company Limited
- Industry
- Eligibility
- 50 Years and older
- Enrollment
- 513 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2024
- U.S. locations
- 34
- States / cities
- Phoenix, Arizona • Little Rock, Arkansas • Los Angeles, California + 30 more
- Conditions
- Parkinson Disease
- Interventions
- BIIB122, BIIB122-Matching Placebo
- Drug
- Lead sponsor
- Biogen
- Industry
- Eligibility
- 30 Years to 80 Years
- Enrollment
- 650 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2026
- U.S. locations
- 33
- States / cities
- Phoenix, Arizona • Sun City, Arizona • Los Angeles, California + 25 more
- Conditions
- Parkinson Disease, Early Parkinson's Disease
- Interventions
- P2B001 0.6/0.75 mg, Rasagiline 0.75 mg, Pramipexole 0.6 mg, Marketed Pramipexole ER
- Drug
- Lead sponsor
- Pharma Two B Ltd.
- Industry
- Eligibility
- 35 Years to 80 Years
- Enrollment
- 544 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2021
- U.S. locations
- 45
- States / cities
- Scottsdale, Arizona • Little Rock, Arkansas • Los Angeles, California + 39 more
- Conditions
- Parkinson Disease
- Interventions
- Tavapadon, Placebo
- Drug
- Lead sponsor
- AbbVie
- Industry
- Eligibility
- 40 Years to 80 Years
- Enrollment
- 529 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2024
- U.S. locations
- 27
- States / cities
- Birmingham, Alabama • Little Rock, Arkansas • Fountain Valley, California + 24 more
- Conditions
- Parkinson's Disease
- Interventions
- Inosine, Placebo
- Drug
- Lead sponsor
- Michael Alan Schwarzschild
- Other
- Eligibility
- 30 Years and older
- Enrollment
- 298 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2019
- U.S. locations
- 61
- States / cities
- Birmingham, Alabama • Phoenix, Arizona • Scottsdale, Arizona + 51 more
- Conditions
- Early Stage Parkinson's Disease
- Interventions
- Pardoprunox, Placebo
- Drug
- Lead sponsor
- Solvay Pharmaceuticals
- Industry
- Eligibility
- 30 Years and older
- Enrollment
- 468 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2007
- U.S. locations
- 24
- States / cities
- Huntsville, Alabama • Little Rock, Arkansas • Fountain Valley, California + 20 more
- Conditions
- Parkinson's Disease
- Interventions
- PYM50028, Placebo
- Drug
- Lead sponsor
- Phytopharm
- Industry
- Eligibility
- 35 Years to 75 Years
- Enrollment
- 425 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2012
- U.S. locations
- 41
- States / cities
- Scottsdale, Arizona • Irvine, California • La Jolla, California + 37 more
- Conditions
- Idiopathic Parkinson's Disease
- Interventions
- Safinamide (as add-on therapy)
- Drug
- Lead sponsor
- Newron Pharmaceuticals SPA
- Industry
- Eligibility
- 30 Years to 80 Years
- Enrollment
- 679 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2012
- U.S. locations
- 31
- States / cities
- Birmingham, Alabama • Phoenix, Arizona • Oxnard, California + 27 more
- Conditions
- Parkinson's Disease
- Interventions
- TCH346 (dibenz[b,f]oxepin-10-ylmethyl-prop-2-ynyl-amine, hydrogen maleate salt)
- Drug
- Lead sponsor
- Novartis
- Industry
- Eligibility
- 30 Years to 80 Years
- Enrollment
- 301 participants
- Timeline
- 2002 – 2003
- U.S. locations
- 11
- States / cities
- Phoenix, Arizona • Berkley, California • Fountain Valley, California + 8 more
- Conditions
- Parkinson Disease
- Interventions
- BHV-8000 10mg, BHV-8000 20 mg, Placebo
- Drug
- Lead sponsor
- Biohaven Therapeutics Ltd.
- Industry
- Eligibility
- 40 Years to 80 Years
- Enrollment
- 550 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2028
- U.S. locations
- 24
- States / cities
- Birmingham, Alabama • Irvine, California • Los Angeles, California + 21 more
- Conditions
- Parkinson Disease
- Interventions
- Isradipine, Placebo (for Isradipine)
- Drug
- Lead sponsor
- University of Rochester
- Other
- Eligibility
- 30 Years and older
- Enrollment
- 336 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2018
- U.S. locations
- 47
- States / cities
- Birmingham, Alabama • Sun City, Arizona • Fountain Valley, California + 40 more
- Conditions
- Parkinson Disease
- Interventions
- BIIB122, BIIB122-Matching Placebo
- Drug
- Lead sponsor
- Biogen
- Industry
- Eligibility
- 30 Years to 80 Years
- Enrollment
- 7 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2023
- U.S. locations
- 12
- States / cities
- San Francisco, California • Aurora, Colorado • Englewood, Colorado + 8 more
- Conditions
- Parkinson Disease
- Interventions
- sumanirole
- Drug
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 30 Years and older
- Enrollment
- 854 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2003 – 2004
- U.S. locations
- 69
- States / cities
- Birmingham, Alabama • Huntsville, Alabama • Little Rock, Arkansas + 60 more
- Conditions
- Early Stage Parkinson Disease
- Interventions
- Pardaprunox, pramipexole, Placebo Comparator
- Drug
- Lead sponsor
- Solvay Pharmaceuticals
- Industry
- Eligibility
- 30 Years and older
- Enrollment
- 330 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2008
- U.S. locations
- 17
- States / cities
- Birmingham, Alabama • Oceanside, California • Oxnard, California + 13 more
- Conditions
- Parkinson Disease
- Interventions
- Placebo, PF-06649751
- Drug
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 45 Years to 80 Years
- Enrollment
- 57 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2018
- U.S. locations
- 20
- States / cities
- Phoenix, Arizona • Boca Raton, Florida • Miami, Florida + 11 more
- Conditions
- Parkinson Disease
- Interventions
- Occupational therapy intervention group, Disease management education group
- Behavioral
- Lead sponsor
- San Jose State University
- Other
- Eligibility
- 18 Years to 85 Years
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2024
- U.S. locations
- 2
- States / cities
- San Jose, California • New York, New York
- Conditions
- Parkinson Disease
- Interventions
- Physical Activity Coaching
- Behavioral
- Lead sponsor
- Teachers College, Columbia University
- Other
- Eligibility
- 18 Years to 85 Years
- Enrollment
- 100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2024
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Parkinson's Disease
- Interventions
- Pioglitazone, placebo
- Drug
- Lead sponsor
- University of Rochester
- Other
- Eligibility
- 30 Years and older
- Enrollment
- 210 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2014
- U.S. locations
- 38
- States / cities
- Birmingham, Alabama • Phoenix, Arizona • Fountain Valley, California + 32 more
- Conditions
- Parkinson's Disease
- Interventions
- CVT-301, LIP, Placebo
- Drug · Other
- Lead sponsor
- Acorda Therapeutics
- Industry
- Eligibility
- 30 Years to 85 Years
- Enrollment
- 36 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016
- U.S. locations
- 11
- States / cities
- Fountain Valley, California • Boca Raton, Florida • Hallandale, Florida + 8 more